Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kyntra Bio (KYNB) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Kyntra Bio (KYNB) over the last 8 years, with Q3 2025 value amounting to $931000.0.

  • Kyntra Bio's Non Operating Income fell 3675.27% to $931000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year decrease of 4503.2%. This contributed to the annual value of $5.3 million for FY2024, which is 3026.07% down from last year.
  • According to the latest figures from Q3 2025, Kyntra Bio's Non Operating Income is $931000.0, which was down 3675.27% from $286000.0 recorded in Q2 2025.
  • Kyntra Bio's Non Operating Income's 5-year high stood at $5.2 million during Q2 2022, with a 5-year trough of -$1.3 million in Q3 2021.
  • In the last 5 years, Kyntra Bio's Non Operating Income had a median value of $924000.0 in 2022 and averaged $1.1 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 18792.17% in 2021, then surged by 153223.14% in 2022.
  • Quarter analysis of 5 years shows Kyntra Bio's Non Operating Income stood at $1.0 million in 2021, then dropped by 11.32% to $924000.0 in 2022, then tumbled by 142.21% to -$390000.0 in 2023, then skyrocketed by 276.41% to $688000.0 in 2024, then skyrocketed by 35.32% to $931000.0 in 2025.
  • Its last three reported values are $931000.0 in Q3 2025, $286000.0 for Q2 2025, and $413000.0 during Q1 2025.